newsfilter
← Latest News
GlobeNewswire·

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

ATLANTA, GA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today